Build. Personalise. Optimise.

Our platform is not hard coded, which makes it easier to create a study for your specific therapeutic area quickly and efficiently, and collect high-quality data specific to your TA protocol.

Combined with our deep domain expertise, our easy-to-build platform enables you to deploy a robust clinical trial at speed and scale for your particular therapeutic area. Achieve higher accuracy with continuous data collection and near real-time reporting.

Powering digital-first clinical research




Connected devices


The Evidence for Decentralized Clinical Trials

Since their creation in the 1940s, Randomised Controlled Trials (RCTs) have been the go-to method for treatment evaluations.

However, the traditional approach to these trials can slow down the research process. The DeTAP study, conducted by the Stanford School of Medicine in partnership with Bayer and Huma, showcased the immense potential of decentralized clinical trials (DCTs).

By adopting a digital-first approach, the study achieved high engagement, rapid recruitment, and increased medication adherence in patients with low baseline.

Read our whitepaper below to uncover the results of one of the first peer-reviewed assessments of a fully decentralized clinical trial:

This field is required
This field is required
This field is required
This field is required
Download now
Thank you for your request.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form

Ready. Set. Go.

Streamlined user journeys help accelerate time to “first patient in” and get your trial up and running with minimal fuss. Our fully integrated screening and consent workflows enable quicker, easier setup and enrollment.

With less time spent on logistics, you’re free to focus on what’s truly at the heart of your clinical study: your participants.

Engaging. Efficient. Clinically proven.

Huma’s award-winning human-centered design has been developed with an understanding of the complex needs of patients and clinicians in mind, enabling us to impact each touchpoint across clinical trial phases. Now you can enroll participants faster and keep them engaged longer for better clinical trial outcomes.

Regulatory, safety and compliance

CE 0297 icon.
EU MDR 2017/745 Class IIb certified

MHRA registered Medical Device Class IIb

US FDA icon.
US FDA 21 CFR compliances Class I exempt and under enforcement discretion

Part 11

Part 50

Part 820 ff

ISO icon.
ISO certifications

ISO 13485: 2016 certified (Medical Devices: Quality Management Systems)

ISO 27001: 2013 certified

Data protection - infosec icon.
Data protection / infosec

Committed to GDPR compliance

NHS Registration on Data Security and Protection Toolkit

CyberEssentials / CyberEssentials Plus

Agile. Quick. Adaptable.

Mid-study changes are inevitable, but Huma makes things simple when they happen. Unlike hard-coded platforms, our highly adaptable platform is designed with flexibility in mind to enable near real-time modifications and additions to study protocols without having to go back to the drawing board.

Request a meeting

This field is required
This field is required
This field is required
This field is required
Country/Region ⃰
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

Thank you.
We will be in touch with you shortly.
Oops! Something went wrong while submitting the form.